Presentation | Follow-up | Within-group difference | |||||
Outcome | Untreated | Treated | Untreated | Treated | Untreated | Treated | Between-group mean difference (95% CI) |
FEV1 (L) | 2.83 | 2.61 | 2.77 | 2.38 | -0.07* | -0.23* | 0.16* (-0.05-0.37) |
FVC (L) | 3.66 | 3.40 | 3.65 | 3.31 | -0.01* | -0.09* | 0.08* (-0.17-0.34) |
FEV1/FVC Ratio | 77.4% | 77.2% | 76.2% | 72.1% | -1.2% | -5.2% | 4% (0.58-7.42) |
FEV1 (centile) | 35.5 | 25.5 | 50.9 | 38.3 | 15.5 | 13.0 | 2.64 (-8.56-13.85) |
FVC (centile) | 46.1 | 32.7 | 68.8 | 58.8 | 22.7 | 26.3 | -3.39 (-17.28-10.50) |
Ratio (centile) | 34.4 | 35.7 | 34.7 | 28.5 | 0.3 | -6.5 | 7.47 (-4.90-19385) |
*L/year change